Kasi Viswanatharaju Ruddraraju

SHP2 is a multifunctional therapeutic target in drug resistant metastatic breast cancer

Hao Chen, Sarah Libring, Kasi Viswanatharaju Ruddraraju et al. · Oncogene · 2020 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

Covalent Allosteric Inactivation of Protein Tyrosine Phosphatase 1B (PTP1B) by an Inhibitor–Electrophile Conjugate

Puminan Punthasee, Adrian R. Laciak, Andrea H. Cummings et al. · Biochemistry · 2017 · 32 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Highly Potent and Selective <i>N</i> -Aryl Oxamic Acid-Based Inhibitors for <i>Mycobacterium tuberculosis</i> Protein Tyrosine Phosphatase B

Kasi Viswanatharaju Ruddraraju, Devesh Aggarwal, Cong‐Wei Niu et al. · Journal of Medicinal Chemistry · 2020 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Allylation and Alkylation of Biologically Relevant Nucleophiles by Diallyl Sulfides

Kasi Viswanatharaju Ruddraraju, Zachary D. Parsons, Calvin D. Lewis et al. · The Journal of Organic Chemistry · 2016 · 27 citations

Natural Sciences, Biochemistry, Chemistry +13

Reactions of 1,3-Diketones with a Dipeptide Isothiazolidin-3-one: Toward Agents That Covalently Capture Oxidized Protein Tyrosine Phosphatase 1B

Kasi Viswanatharaju Ruddraraju, Zachary D. Parsons, Elizabeth M. Llufrio et al. · The Journal of Organic Chemistry · 2015 · 18 citations

Life Sciences, Biochemistry, Pharmacology +17